OXFORD_NEUROPATHOLOGY_SER - Accounts


Company Registration Number 05424292 (England and Wales)
OXFORD NEUROPATHOLOGY SERVICES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2017
PAGES FOR FILING WITH REGISTRAR
OXFORD NEUROPATHOLOGY SERVICES LIMITED
BALANCE SHEET
AS AT
30 APRIL 2017
30 April 2017
- 1 -
2017
2016
£
£
£
£
Fixed assets
67,272
169,066
Current assets
413,368
314,121
Creditors: amounts falling due within one year
(11,755)
(6,228)
Net current assets
401,613
307,893
Total assets less current liabilities
468,885
476,959
Accruals and deferred income
(1,800)
(1,800)
Net assets
467,085
475,159
Capital and reserves
467,085
475,159
Notes to the financial statements
Directors' benefits: advances, credit and guarantees

During the year an amount of £306,800 was advanced to the director, Dr W Squier, with amounts repaid of £9,957 and interest charged at a rate of 3% of £5,964. The amount owed to the company at the year end was £303,390 (2016: £583). £200,000 of this has been repaid in July 2017 and the remaining balance will be repaid by January 2018.

OXFORD NEUROPATHOLOGY SERVICES LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 APRIL 2017
30 April 2017
- 2 -

Oxford Neuropathology Services Limited is a private company limited by shares incorporated in England and Wales. The registered office is Units 4 & 5, Swinford Farm, Eynsham, Oxford, OX29 4BL.

 

The director of the company have elected not to include a copy of the profit and loss account within the financial statements.false

For the year ended 30 April 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 4 December 2017
Dr W Squier
Director
Company Registration Number 05424292
2017-04-302016-05-01falseCCH SoftwareCCH Accounts Production 2017.300providing neuropathology services054242922016-05-012017-04-30054242922017-04-30054242922016-04-3005424292core:CurrentFinancialInstruments2017-04-3005424292core:CurrentFinancialInstruments2016-04-3005424292bus:PrivateLimitedCompanyLtd2016-05-012017-04-3005424292bus:Micro-entities2016-05-012017-04-3005424292bus:AuditExemptWithAccountantsReport2016-05-012017-04-3005424292bus:SmallCompaniesRegimeForAccounts2016-05-012017-04-3005424292bus:FullAccounts2016-05-012017-04-30xbrli:purexbrli:sharesiso4217:GBP